tirzepatide breastfeeding data on Mounjaro: What New Research Says If you’re on a GLP-1

What is the evidence regarding the safety of new obesity pharmacotherapies

Our competitive pricing options include: For those without insurance coverage or who prefer not to use their insurance, we offer self-pay options

Coverage and approval are not guaranteed

Its safety profile is generally consistent with other GLP-1-based therapies, with common side effects including nausea, diarrhea, and decreased appetite

If you notice any other effects, check with your healthcare professional

People most at risk include those who: have type 2 diabetes use insulin or sulfonylurea miss meals have recently increased their dose Symptoms of low blood sugar can include: shaking sweating dizziness hunger headache confusion feeling faint If hypoglycaemia is suspected, it should be treated immediately with fast-acting carbohydrates, such as glucose tablets or a sugary drink